Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06372249 · ClinicalTrials.gov registry record · Phase 2
A Clinical Trial of Soluble Fiber for Asthma
A Phase 2 study of Asthma in Children, sponsored by Phoenix Children's Hospital.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT06372249: Recruiting Phase 2 study of Asthma in Children, sponsored by Phoenix Children's Hospital.
NCT06372249 is a Phase 2 study of Asthma in Children that is actively recruiting participants, run by Phoenix Children's Hospital. The registered enrollment target is 105 participants, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06372249, a Phase 2 study of Asthma in Children, is actively recruiting participants, sponsored by Phoenix Children's Hospital.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants will be supplemented to their target fiber dosage with either soluble fiber (Fruitafit Inulin) or placebo. Collection of blood serum, fecal samples, and nasal wash will aid in analyzing the microbes present in one's gut and how fiber and diet may impact it. Thus, allowing researchers to better understand the pathways that may connect diet and asthma and if it is possible to improve asthma by altering one's diet.
Primary Outcome
A total of 84 participants is required to find significant difference of 54 units of Richness at 90% power with a small effect size. Alpha diversity is used to measure the abundance that individual microbes can be observed. Statistical analysis is used to generate the significance of stool sample diversity as well as how many participants are needed to see the marker.
Conditions Studied
Interventions
- DRUG Inulin
Study Locations (1)
Arizona
- Phoenix Children's - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2025-11-10 |
| Est. Completion | 2027-05-31 |
| Phase | Phase 2 |
What NCT06372249 shows while recruiting
NCT06372249 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 1 intervention - of which Inulin is the first listed.
NCT06372249 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06372249 about?
NCT06372249 is a clinical study titled "A Clinical Trial of Soluble Fiber for Asthma". Randomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants will be supplemented to their target fiber dosage with either soluble fiber (Fruitafit Inulin) or p...
What is the current status of trial NCT06372249?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2025-11-10. Estimated completion is 2027-05-31.
What conditions does trial NCT06372249 study?
This clinical trial studies the following conditions: Asthma in Children.
What interventions are being tested in trial NCT06372249?
The interventions under investigation include: Inulin (DRUG).
Who is sponsoring clinical trial NCT06372249?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06372249 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06372249's enrollment target sits among peer trials
105 21st of 44 higher than 24 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
RECRUITING · Phase 2
-
Omalizumab Before Onset of Exacerbations
RECRUITING · Phase 2
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
Wearable Electronic Breath Sound Sensing Device
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI